This inventor holds 6 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignees: Regeneron Pharmaceuticals, Inc., Regeneran Pharmaceuticals, Inc.. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
5 out of 1,482 
1 out of 49 Years Active: 2022-2026
Title: Innovations and Contributions of Olga Sineshchekova
Introduction
Olga Sineshchekova is a prominent inventor based in Pleasantville, NY (US). She has made significant contributions to the field of biotechnology, particularly in cancer treatment. With a total of five patents to her name, her work focuses on innovative methods and compositions that address critical medical challenges.
Latest Patents
Among her latest patents, one notable invention is related to compositions and methods for treating cytokine release syndrome (CRS). This invention provides compositions and methods for treating cancer and inhibiting CRS. The methods involve administering a therapeutically effective amount of a CD40 antagonist or a CAR-T cell expressing a CD40 antagonist, combined with a CD3 multispecific antigen binding molecule. Another significant patent involves nucleic acid molecules encoding bispecific anti-BCMA x anti-CD3 antibodies. This invention targets B-cell maturation antigen (BCMA) expressed on malignant plasma cells, providing novel bispecific antibodies that activate T cells in the presence of BCMA-expressing tumor cells. These bispecific antigen-binding molecules are particularly useful for treating various cancers, including multiple myeloma.
Career Highlights
Olga has worked with notable companies in the biotechnology sector, including Regeneron Pharmaceuticals, Inc. and Regeneron Pharmaceuticals, Inc. Her experience in these organizations has contributed to her expertise in developing innovative therapeutic solutions.
Collaborations
Olga has collaborated with several professionals in her field, including Eric L. Smith and Kara Olson. These collaborations have likely enhanced her research and development efforts, leading to impactful innovations.
Conclusion
Olga Sineshchekova's contributions to biotechnology and cancer treatment through her patents demonstrate her commitment to advancing medical science. Her innovative approaches have the potential to significantly improve patient outcomes in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile